Announcement on Progress in Repurchasing Shares
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/chengdu-easton-biopharmaceuticals-co-ltdannouncement-on-progress-in-repurchasing-shares
Chengdu Easton Biopharmaceuticals Co., Ltd. on 6ix
Earlier from Chengdu Easton Biopharmaceuticals
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of the Initiation of Phase I/II Clinical Trial for HP-002 Tablets and Completion of First Subject Enrollment and Dosing
- Announcement on Voluntary Disclosure of Proposed Selection in the National Centralized Drug Procurement
- Announcement on the Voluntary Disclosure of Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection
- Announcement on Abnormal Fluctuations in Stock Trading
Later from Chengdu Easton Biopharmaceuticals
- Announcement on Implementation Results of Share Repurchase
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Announcement on Resolutions of the 16th Meeting of the 4th Board of Directors
- Announcement on Voluntary Disclosure of Progress of Phase I Clinical Trials for EP-0226 Tablets
Follow Chengdu Easton Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Easton Biopharmaceuticals